Santen Pharmaceutical Statistics

Total Valuation

SNPHF has a market cap or net worth of 4.01 billion. The enterprise value is 3.35 billion.

Market Cap	4.01B
Enterprise Value	3.35B

Important Dates

The next estimated earnings date is Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Current Share Class	341.36M
Shares Outstanding	n/a
Shares Change (YoY)	-5.01%
Shares Change (QoQ)	-0.98%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	334.77M

Valuation Ratios

The trailing PE ratio is 16.55.

PE Ratio	16.55
Forward PE	n/a
PS Ratio	2.00
PB Ratio	2.10
P/TBV Ratio	2.85
P/FCF Ratio	11.05
P/OCF Ratio	9.84
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.25, with an EV/FCF ratio of 9.25.

EV / Earnings	13.85
EV / Sales	1.61
EV / EBITDA	7.25
EV / EBIT	9.93
EV / FCF	9.25

Financial Position

The company has a current ratio of 2.58

Current Ratio	2.58
Quick Ratio	1.90
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	18.15

Financial Efficiency

Return on equity (ROE) is 12.14% and return on invested capital (ROIC) is 9.85%.

Return on Equity (ROE)	12.14%
Return on Assets (ROA)	7.29%
Return on Invested Capital (ROIC)	9.85%
Return on Capital Employed (ROCE)	15.28%
Revenue Per Employee	535,094
Profits Per Employee	64,651
Employee Count	3,744
Asset Turnover	0.71
Inventory Turnover	2.72

Taxes

In the past 12 months, SNPHF has paid 77.65 million in taxes.

Income Tax	77.65M
Effective Tax Rate	24.49%

Stock Price Statistics

The stock price has increased by +7.00% in the last 52 weeks. The beta is 0.22, so SNPHF's price volatility has been lower than the market average.

Beta (5Y)	0.22
52-Week Price Change	+7.00%
50-Day Moving Average	10.36
200-Day Moving Average	8.46
Relative Strength Index (RSI)	55.81
Average Volume (20 Days)	748

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SNPHF had revenue of 2.00 billion and earned 242.05 million in profits. Earnings per share was 0.69.

Revenue	2.00B
Gross Profit	1.14B
Operating Income	329.10M
Pretax Income	317.07M
Net Income	242.05M
EBITDA	448.95M
EBIT	329.10M
Earnings Per Share (EPS)	0.69

Full Income Statement

Balance Sheet

The company has 621.02 million in cash and n/a in debt, giving a net cash position of 621.02 million.

Cash & Cash Equivalents	621.02M
Total Debt	n/a
Net Cash	621.02M
Net Cash Per Share	n/a
Equity (Book Value)	1.90B
Book Value Per Share	5.60
Working Capital	917.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 406.87 million and capital expenditures -44.49 million, giving a free cash flow of 362.38 million.

Operating Cash Flow	406.87M
Capital Expenditures	-44.49M
Free Cash Flow	362.38M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 57.07%, with operating and profit margins of 16.43% and 12.09%.

Gross Margin	57.07%
Operating Margin	16.43%
Pretax Margin	15.83%
Profit Margin	12.09%
EBITDA Margin	22.41%
EBIT Margin	16.43%
FCF Margin	18.09%

Dividends & Yields

This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 2.23%.

Dividend Per Share	0.25
Dividend Yield	2.23%
Dividend Growth (YoY)	11.90%
Years of Dividend Growth	1
Payout Ratio	33.40%
Buyback Yield	5.01%
Shareholder Yield	7.24%
Earnings Yield	6.04%
FCF Yield	9.05%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SNPHF has an Altman Z-Score of 5.08 and a Piotroski F-Score of 6.

Altman Z-Score	5.08
Piotroski F-Score	6